Open-angle glaucoma and mortality: The Barbados eye studies

Archives of Ophthalmology

Volumn 126, Issue 3, 2008, Pages 365-370

  Wu, Suh Yuh ^a   Nemesure, Barbara ^a   Hennis, Anselm ^a,b,c   Schachat, Andrew P ^d   Hyman, Leslie ^a   Leske, M Cristina ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Ministry of Health Barbados   (Barbados)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; PILOCARPINE; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEATH CERTIFICATE; EYE INJURY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OPEN ANGLE GLAUCOMA; OPTIC DISK; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BARBADOS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC DISK; PROPORTIONAL HAZARDS MODELS; VISION DISORDERS; VISUAL FIELDS;

EID: 40849142106     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archophthalmol.2007.77     Document Type: Article

References (43)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-851.
2. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore Eye Survey. JAMA. 1991;266(3):369-374.
3. Leske MC, Connell AMC, Schachat A, et al. The Barbados Eye Study: prevalence of open-angle glaucoma. Arch Ophthalmol. 1994;112(6):821-829.
4. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325(20):1412-1417.
5. Hyman L, Wu S-Y, Connell AMS, et al. Prevalence and causes of visual impairment in the Barbados Eye Study. Ophthalmology. 2001;108(10):1751- 1756.
6. Hiller R, Podgor MJ, Sperduto RD, et al. High intraocular pressure and survival: The Framingham Studies. Am J Ophthalmol. 1999;128(4):440-445.
7. Lee DJ, Gomez-Marin O, Lam BL, Zheng DD. Glaucoma and survival: The National Health Interview Survey 1986-1994. Ophthalmology. 2003;110(8):1476-1483.
8. Grødum K, Heijl A, Bengstsson B. Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol. 2004;242(5):397-401.
9. Klein R, Klein BEK, Moss SE. Age-related eye disease and survival: The Beaver Dam Eye Study. Arch Ophthalmol. 1995;113(3):333-339.
10. Knudtson MD, Klein BE, Klein R. Age-related eye disease, visual impairment, and survival: The Beaver Dam Eye Study. Arch Ophthalmol. 2006;124(2):243-249.
11. Taylor HR, McCarty CA, Nanjan MB. Vision impairment predicts five-year mortality. Trans Am Ophthalmol Soc. 2000;98:91-99.
12. Borger PH, van Leeuwen R, Hulsman CAA, et al. Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology. 2003;110(7):1292-1296.
13. Lee AJ, Wang JJ, Kiefley A, Mitchell P. Open-angle glaucoma and cardiovascular mortality: The Blue Mountains Eye Study. Ophthalmology. 2006;113(7):1069-1076.
14. Leske MC. Glaucoma and mortality: a connection? [editorial]. Ophthalmology. 2003;110(8):1473-1475.
15. Leske MC, Connell AMS, Wu S-Y, et al. Incidence of open-angle glaucoma. Arch Ophthalmol. 2001;119(1):89-95.
16. Friedman DS, Wolfs RC, O'Colmain BJ, et al; The Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532-538.
17. Leske MC, Connell AMS, Wu SY, et al. Distribution of intraocular pressure: The Barbados Eye Study. Arch Ophthalmol. 1997;115(8):1051-1057.
18. Wu SY, Nemesure B, Leske MC. Observed vs indirect estimates of open-angle glaucoma. Am J Epidemiol. 2001;153(2):184-187.
19. Leske MC, Wu SY, Nemesure B, et al. Nine-year incidence of lens opacities in the Barbados Eye Studies. Ophthalmology. 2004;111(3):483-490.
20. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
21. Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;B34:187-220.
22. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. WHO Bull. 1962;27:645-658.
23. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117(11):1487-1495.
24. Egge K, Zahl PH. Survival of glaucoma patients. Acta Ophthalmol Scand. 1999;77(4):397-401.
25. Stewart WC, Garrison PM. Beta-blocker-induced complications and the patient with glaucoma: newer treatments to help reduce systemic adverse events. Arch Intern Med. 1998;158(3):221-226.
26. Frishman WH, Kowalski M, Shreedhar N, et al. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on β-adrenergic blockade. Heart Dis. 2001;3(6):386-397.
27. Dahlöf B, Sever NR, Wedel H, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet. 2005;366(9489):895-906.
28. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279.
29. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713.
30. Diggory P, Franks WA. Glaucoma therapy may take your breath away. Age Ageing. 1997;26(2):63-67.
31. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115(12):1572-1576.
32. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma: The Barbados Eye Study. Arch Ophthalmol. 1995;113(7):918-924.
33. Leske MC, Wu SY, Nemesure B, et al. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol. 2002;120(7):954-959.
34. Wu SY, Nemesure B, Hennis A, Leske MC; Barbados Eye Studies Group. Nineyear changes in intraocular pressure: The Barbados Eye Studies. Arch Ophthalmol. 2006;124(11):1631-1636.
35. Klein BEK, Klein R, Linton KLP. Intraocular pressure in an American community: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33(7):2224-2228.
36. Carel RS, Korczyn AD, Rock M, et al. Association between ocular pressures and certain health parameters. Ophthalmology. 1984;99:837-839.
37. Hennis A, Wu SY, Nemesure B, Leske MC; Barbados Eye Studies Group. Hypertension, diabetes and longitudinal changes in intraocular Pressure. Ophthalmology. 2003;110(5):908-914.
38. Nemesure B, Wu SY, Hennis A, Leske MC; Barbados Eye Studies Group. Factors related to the 4-year risk of "high" intraocular pressure: The Barbados Eye Studies. Arch Ophthalmol. 2003;121(6):856-862.
39. Cobley AG, Thompson A. The African-Caribbean Connection: Historical and Cultural Perspectives. Bridgetown, Barbados: Dept of History; 1990.
40. Holder Y, Lewis MJ. Epidemiological Overview of Morbidity and Mortality: Health Conditions in the Caribbean. Vol 561. Geneva, Switzerland: Pan American Health Organization Scientific Publication; 1997:22-61.
41. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-313.
42. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21(4):518-524.
43. Pan American Health Organization. Health Analysis and Information Systems Area. Washington, DC: Regional Core Health Data Initiative, Technical Health Information System; 2005.